Remove companies mirati-therapeutics-inc
article thumbnail

Amgen's Adcomm Meeting Paves Way To Launch Boost For Mirati Therapeutics' Lung Cancer Drug: Analysts

Benzinga

According to a report on Thursday, French pharma company Sanofi SA (NASDAQ: SNY ) is reportedly exploring a potential acquisition of cancer drugmaker Mirati Therapeutics Inc (NASDAQ: MRTX ). Sanofi's backing would also help Mirati commercialize Krazati and fund treatment and further studies, Bloomberg noted.

59
article thumbnail

Mirati Therapeutics Garners Interest From Large Pharmas Ahead Of Much Awaited Data Next Month

Benzinga

Mirati Therapeutics Inc (NASDAQ: MRTX ) is reportedly amid fresh takeover interest from large pharmaceutical companies ahead of updates on its drug pipeline. For some time, the cancer-focused company has been weighing strategic options, including a potential sale.

52